[Federal Register: November 3, 2004 (Volume 69, Number 212)]
[Notices]               
[Page 64072-64073]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03no04-82]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2003D-0383]

 
Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Recommended Glossary and Educational 
Outreach to Support Use of Symbols on Labels and in Labeling of In 
Vitro Diagnostic Devices Intended for Professional Use

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Recommended Glossary and 
Educational Outreach to Support Use of Symbols on Labels and in 
Labeling of In Vitro Diagnostic Devices Intended for Professional Use'' 
has been approved by the Office of Management and Budget (OMB) under 
the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Peggy Robbins, Office of Management 
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-1223.

SUPPLEMENTARY INFORMATION: In the Federal Register of August 5, 2004 
(69 FR 47448), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0553. 
The approval expires on October 31, 2007. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/ohrms/dockets.



[[Page 64073]]


    Dated: October 27, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-24447 Filed 11-2-04; 8:45 am]

BILLING CODE 4160-01-S